Text Size

Evaluation of an Intervention Program for the Prevention of Anemia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Wolfson Medical Center.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Tel Aviv District of the Health Office
Information provided by:
Wolfson Medical Center
ClinicalTrials.gov Identifier:
NCT00436202
First received: February 15, 2007
Last updated: September 12, 2010
Last verified: September 2010
History of Changes
  Purpose

The purpose of the study is to determine whether improvement in the accessibility to iron supplement will decrease anemia rates in infants.


Condition Intervention
Anemia
 Behavioral: Iron supplement

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Wolfson Medical Center:

Detailed Description:

Iron deficiency anemia is the most common type of anemia in infants, children and women of reproductive age. The most frequent cause of iron deficiency in infants at 6 months of life is poor nutrition during a period of rapid growth and a diet lacking in iron rich foods. Children who suffered from anemia in infancy demonstrated slower cognitive development, were low achievers in school and had a high rate of behavioral disturbances.

The Ministry of Health implements a primary prevention program for anemia. If by making iron supplements more accessible would increase parental compliance in acquisition of the iron supplement and subsequently reduce the rate of iron deficiency anemia, the result would be the immediate application of the finding. It is possible to implement a program whereby the supplement will be directly available at the family health centers for purchase by the parent.

  Eligibility

Ages Eligible for Study:   4 Months and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Infant who visit Family Health Centers
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00436202

Locations
Israel
Tel Aviv District of the Health Office
Tel Aviv, Israel
Sponsors and Collaborators
Wolfson Medical Center
Tel Aviv District of the Health Office
Investigators
Principal Investigator: Tamar Shohat, M.D., MPH Tel Aviv District of the Health Office
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00436202     History of Changes
Other Study ID Numbers: Anemia
Study First Received: February 15, 2007
Last Updated: September 12, 2010
Health Authority: Israel: Ministry of Health

Keywords provided by Wolfson Medical Center:
Anemia
Iron
Supplement

Additional relevant MeSH terms:
Anemia
Hematologic Diseases

ClinicalTrials.gov processed this record on May 16, 2013